Table 3.
Parenchymal stages and pulmonary embolism.
| Total (n = 114) | PE (n = 65) | Non-PE (n = 49) | p-value (p < 0.001) | |
|---|---|---|---|---|
| Stages | 0.229 | |||
| Early | 6 (5.3 %) | 1 (1.5 %) | 5 (10.2 %) | |
| Progressive | 26 (22.8 %) | 16 (24.6 %) | 10 (20.4 %) | |
| Peak | 74 (64.9 %) | 44 (67.7 %) | 30 (61.2 %) | |
| Absorption | 8 (7%) | 4 (6.2 %) | 4 (8.2 %) |
Data presented as n (%). Differences with two-sided p-values above 0.001 not deemed as statistically strongly significant.